# Ayr Wellness Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/Ayr Wellness Inc.). ## Overview Ayr Wellness Inc. is a U.S.-based vertically integrated cannabis company that cultivates, manufactures, and sells cannabis products through a network of licensed retail locations. Its operations span multiple state markets, serving medical patients and adult-use consumers with both plant-based products and branded consumer packaged goods. ## Products & services • Licensed cannabis retail dispensaries • Cultivation and processing of cannabis flower • Manufactured cannabis products and derivatives • Branded CPG products under Kynd, Haze, and Later Days • Medical cannabis products for registered patients • Adult-use cannabis products for recreational consumers - **Retail dispensaries** (45%) — Company-operated stores that sell cannabis products directly to consumers and patients. - **Cultivation and flower** (20%) — Grown cannabis biomass and flower used in wholesale and retail channels. - **Manufactured products** (20%) — Processed cannabis items such as concentrates, edibles, and other derivatives. - **Branded consumer products** (15%) — Packaged cannabis brands sold across the company's retail and wholesale network. - Licensed cannabis retail dispensaries - Cultivation and processing of cannabis flower - Manufactured cannabis products and derivatives - Branded CPG products under Kynd, Haze, and Later Days - Medical cannabis products for registered patients - Adult-use cannabis products for recreational consumers ## Customers AYR sells primarily to medical cannabis patients, adult-use consumers, and, in some markets, wholesale channel partners. Its customers buy for therapeutic use, personal consumption, and branded product preference, with demand shaped by state regulations, product format, and local retail access. - **Medical cannabis patients** (primary) — Registered patients buying cannabis products for therapeutic use and regulated access. - **Adult-use consumers** (primary) — Recreational consumers purchasing legal cannabis through company retail locations. - **Wholesale and channel partners** (secondary) — Buyers of branded or manufactured cannabis products for resale in regulated markets. - **Brand-focused consumers** (secondary) — Customers choosing products by brand and format, especially Kynd, Haze, and Later Days. - Medical patients seeking physician-recommended cannabis products - Adult-use consumers purchasing for recreational consumption - Retail shoppers buying flower, concentrates, and manufactured formats - Brand-sensitive buyers choosing Kynd, Haze, or Later Days - State-regulated market customers who need local legal access ## Geography AYR operates across several U.S. state cannabis markets, including Florida, Pennsylvania, Massachusetts, New Jersey, Ohio, Nevada, and Virginia. Because cannabis is regulated at the state level, the company's footprint is shaped by licensing rules, local retail access, and each state's mix of medical and adult-use demand. - **United States** (100%) — Operations are U.S.-based across multiple state markets. - Operations are concentrated in U.S. state-licensed cannabis markets - Florida is a core operating market for cultivation and retail - Pennsylvania and Massachusetts support medical cannabis demand - New Jersey, Ohio, Nevada, and Virginia broaden state exposure - State-level regulation makes local licensing and compliance critical ## Strategy AYR's business model depends on controlling cultivation, manufacturing, and retail in regulated cannabis markets, which allows it to capture value across the product chain. Its branded product portfolio and multi-state footprint are intended to deepen consumer loyalty, broaden product reach, and reduce dependence on any single market. - **Multi-state retail and operating scale** (medium-term) — A broader store and operating base supports access to more customers and reduces reliance on one state. - **Branded product expansion** (medium-term) — Consumer brands can strengthen repeat purchasing and differentiate the company's products in a crowded market. - **Vertical integration** (long-term) — Owning cultivation, manufacturing, and retail can improve product control and margin capture. - Integrate cultivation, manufacturing, and retail to keep value in-house - Expand licensed store network in key state markets - Grow branded products to improve customer loyalty and shelf presence - Serve both medical and adult-use channels to diversify demand - Build scale across multiple state regimes to reduce single-state dependence ## Risks AYR faces regulatory, licensing, and operating risks that are inherent to the U.S. cannabis industry, where rules differ by state and can change over time. Its performance is also exposed to execution risk in retail, cultivation, and brand building, as well as broader cannabis industry risks such as pricing pressure, product quality control, and compliance failures. - **State regulatory and licensing risk** [high] — Cannabis is regulated at the state level, so rule changes can affect store operations, product offerings, and growth plans. - **Operational compliance risk** [high] — Cultivation, manufacturing, and retail all require strict controls, and failures can lead to product, licensing, or shutdown issues. - **Geographic concentration in U.S. state markets** [medium] — The company depends on a limited number of regulated state markets rather than a diversified national market. - **Cannabis pricing and demand volatility** [medium] — Local supply growth, competition, and consumer preference shifts can affect sales and product mix. - State cannabis regulation can change access, licensing, and product rules - Retail and cultivation operations require strict compliance and quality control - Heavy dependence on U.S. state markets creates geographic concentration risk - Cannabis pricing can be volatile as legal supply expands - Brand and store execution matter because customers can switch easily ## Accounting Ayr's accounting is shaped by the cannabis supply chain, where inventory, biological assets, and retail activity can require judgment on valuation, timing, and obsolescence. Cannabis operators also face significant lease accounting because dispensaries and production sites are typically housed in leased facilities, and state-by-state operations can create uneven quarterly results. - **Inventory valuation and obsolescence** — Retail, cultivation, and manufactured product inventory - **Lease accounting** — Store and facility footprint - **Biological asset measurement** — Cultivation accounting - **Seasonality and quarterly comparability** — Reported quarterly performance - Inventory valuation and obsolescence in cannabis products - Biological asset and cultivation cost measurement - Lease accounting for dispensaries and grow facilities - Quarterly seasonality from state retail demand patterns - Brand and asset impairment if market conditions weaken --- *Last updated: 2026-09-28T11:57:45.689351+00:00*